PHG Stock Overview
Operates as a health technology company in North America, the Greater China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Koninklijke Philips N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5,830.00 |
| 52 Week High | €8,170.00 |
| 52 Week Low | €3,089.93 |
| Beta | 0.79 |
| 11 Month Change | -23.79% |
| 3 Month Change | -22.99% |
| 1 Year Change | 61.73% |
| 33 Year Change | 251.18% |
| 5 Year Change | n/a |
| Change since IPO | 62,571.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHG | AR Medical Equipment | AR Market | |
|---|---|---|---|
| 7D | -4.4% | 0% | 0% |
| 1Y | 61.7% | 0% | 0% |
Return vs Industry: PHG exceeded the AR Medical Equipment industry which returned 16.1% over the past year.
Return vs Market: PHG underperformed the AR Market which returned 198.8% over the past year.
Price Volatility
| PHG volatility | |
|---|---|
| PHG Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in AR Market | 0% |
| 10% least volatile stocks in AR Market | 0% |
Stable Share Price: PHG has not had significant price volatility in the past 3 months compared to the AR market.
Volatility Over Time: PHG's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1891 | 68,701 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
| PHG fundamental statistics | |
|---|---|
| Market cap | AR$24.11t |
| Earnings (TTM) | -AR$492.90b |
| Revenue (TTM) | AR$18.96t |
1.3x
P/S Ratio-48.9x
P/E RatioIs PHG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHG income statement (TTM) | |
|---|---|
| Revenue | €18.04b |
| Cost of Revenue | €10.43b |
| Gross Profit | €7.61b |
| Other Expenses | €8.08b |
| Earnings | -€469.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 03, 2025
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 42.18% |
| Net Profit Margin | -2.60% |
| Debt/Equity Ratio | 69.4% |
How did PHG perform over the long term?
See historical performance and comparison